MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

NCT05108740 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Advanced Hormone Receptor Positive (HR+) Breast Cancer

Interventions

DRUG: everolimus

Sponsor

Novartis Pharmaceuticals